| Product Code: ETC070069 | Publication Date: Aug 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Vietnam Biobanking Market was estimated at USD 817 Million in 2025 and is projected to reach USD 1160 Million by 2032, growing at a CAGR of 5.1% from 2026 to 2032. This growth trajectory is primarily driven by a surge in biomedical research initiatives, coupled with an increased emphasis on personalized medicine. The expansion of healthcare infrastructure and governmental support for medical research are pivotal in establishing robust biobanks across the country, which are now recognized as invaluable assets for scientific inquiry.
The Vietnam biobanking market has shown a notable upward trend, with growth rates fluctuating in recent years. After a modest increase of 2.9% in 2021, the sector experienced a slight dip to 2.8% in 2022. However, 2023 marked a significant rebound with an impressive 8.8% growth, driven by heightened consumer demand for personalized medicine and advances in biotechnology. This momentum is expected to continue, with projections of 5.6% in 2024 and 6.5% in 2025 as investments in infrastructure and digitalization of health services gain traction. By 2026, growth could reach 8.4%, reflecting increased funding from both governmental and private entities focused on healthcare innovation, ensuring the market remains vibrant in the years ahead.
This graph highlights how the Vietnam Biobanking Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 2.9% | Expansion of commercial construction activities |
| 2022 | 2.8% | Rising electricity demand across industries |
| 2023 | 8.8% | Increasing adoption of advanced technologies |
| 2024 | 5.6% | Government infrastructure modernization initiatives |
| 2025 | 6.5% | Increasing adoption of advanced technologies |
| 2026 | 8.4% | Rapid growth in telecom and data center sectors |
| 2027 | 7.6% | Expansion of commercial construction activities |
| 2028 | 6.3% | Rapid growth in telecom and data center sectors |
| 2029 | 6.3% | Increasing industrial infrastructure investments |
| 2030 | 6.0% | Increasing industrial infrastructure investments |
| 2031 | 5.9% | Increasing industrial automation investments |
| 2032 | 5.2% | Rapid growth in telecom and data center sectors |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
Vietnam is witnessing a significant transformation in its biobanking landscape, as both research institutions and biopharmaceutical companies actively seek to leverage biological sample preservation. With a concerted push towards modernized healthcare and innovative medical research, the importance of biobanks as repositories of biological materials cannot be overstated.
Recent developments in genetic research and a deeper understanding of molecular biology are propelling the need for high-quality biological samples. Biobanks are facilitating comprehensive data management and storage practices, thereby enabling healthcare professionals to unlock critical insights that drive advancements in diagnosis and treatment.
While the Vietnam Biobanking Market holds immense potential, several restraints hamper its growth trajectory. Funding remains a significant concern; the financial resources needed for establishing and maintaining biobanks are considerable. Public and private sector investment in sustainable funding mechanisms is vital to support long-term biobanking initiatives. Furthermore, the lack of standardized protocols for sample collection, storage, and data management poses challenges in preserving the quality of biological specimens, which is essential for future research validity and reliability.
Current trends indicate a growing integration of advanced technologies such as artificial intelligence and machine learning within biobanking processes. These innovations enhance data analysis capabilities, optimize sample management, and facilitate personalized medicine approaches. Additionally, collaboration between public health organizations and biobanks is increasing, providing a more holistic approach to research and healthcare solutions.
Genuine growth opportunities lie in expanding the biobanking infrastructure to accommodate emerging fields such as regenerative medicine and genomics. Increased awareness and education on the benefits of biobanking can further stimulate investment. Furthermore, the establishment of strategic partnerships with international biobanks may enhance resource sharing and collaborative research efforts, paving the way for Vietnam to become a notable player in the global biobanking landscape.
The Vietnamese government has initiated various policies aimed at bolstering biomedical research, which directly impacts the biobanking sector. These initiatives include funding for research institutions, infrastructure development, and support for public-private partnerships. Additionally, there are programs designed to enhance the capabilities of local biobanks, ensuring they meet international standards and best practices in biological sample management.
Looking forward to 2026-2032, the Vietnam Biobanking Market is set to evolve significantly, driven by advancements in medical technologies and research methodologies. The increasing focus on genetic and personalized medicine will likely expand the demand for biobanking services. As healthcare providers strive to integrate biobanking into routine medical practices, opportunities for growth will multiply, making Vietnam a regional hub for biobanking services.
Recent developments indicate a noticeable shift towards enhanced collaboration within the biobanking sector. As healthcare demands evolve, several initiatives are underway to improve sample collection protocols and storage technologies. Furthermore, public health organizations are increasingly partnering with biobanks to address emerging health challenges, demonstrating the growing recognition of biobanks' critical roles in supporting healthcare research and solutions.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Biobanking Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Biobanking Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Biobanking Market - Industry Life Cycle |
3.4 Vietnam Biobanking Market - Porter's Five Forces |
3.5 Vietnam Biobanking Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Vietnam Biobanking Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 Vietnam Biobanking Market Revenues & Volume Share, By Sample Type, 2022 & 2032F |
4 Vietnam Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Biobanking Market Trends |
6 Vietnam Biobanking Market, By Types |
6.1 Vietnam Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Biobanking Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 Vietnam Biobanking Market Revenues & Volume, By Equipment, 2022-2032F |
6.1.4 Vietnam Biobanking Market Revenues & Volume, By Consumables, 2022-2032F |
6.1.5 Vietnam Biobanking Market Revenues & Volume, By Services, 2022-2032F |
6.1.6 Vietnam Biobanking Market Revenues & Volume, By Software, 2022-2032F |
6.2 Vietnam Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Biobanking Market Revenues & Volume, By Regenerative Medicine, 2022-2032F |
6.2.3 Vietnam Biobanking Market Revenues & Volume, By Life Science Research, 2022-2032F |
6.2.4 Vietnam Biobanking Market Revenues & Volume, By Clinical Research, 2022-2032F |
6.3 Vietnam Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Biobanking Market Revenues & Volume, By Blood Products, 2022-2032F |
6.3.3 Vietnam Biobanking Market Revenues & Volume, By Human Tissues, 2022-2032F |
6.3.4 Vietnam Biobanking Market Revenues & Volume, By Nucleic Acids, 2022-2032F |
6.3.5 Vietnam Biobanking Market Revenues & Volume, By Cell Lines, 2022-2032F |
6.3.6 Vietnam Biobanking Market Revenues & Volume, By Biological Fluids, 2022-2032F |
6.3.7 Vietnam Biobanking Market Revenues & Volume, By Human Waste Products, 2022-2032F |
7 Vietnam Biobanking Market Import-Export Trade Statistics |
7.1 Vietnam Biobanking Market Export to Major Countries |
7.2 Vietnam Biobanking Market Imports from Major Countries |
8 Vietnam Biobanking Market Key Performance Indicators |
9 Vietnam Biobanking Market - Opportunity Assessment |
9.1 Vietnam Biobanking Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Vietnam Biobanking Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 Vietnam Biobanking Market Opportunity Assessment, By Sample Type, 2022 & 2032F |
10 Vietnam Biobanking Market - Competitive Landscape |
10.1 Vietnam Biobanking Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here